Xinghua Yu

Xinghua Yu

Auto-generated profile, based on publicly available information

Xinghua Yu

Graduate School at Shenzhen Tsinghua University Shenzhen 518055 China

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2016 in Advanced Materials
Verified
Journal Article
Closed access
PDF file
WTWei Tao
Wei Tao
XZXianbing Zhu
Xianbing Zhu
XYXinghua Yu
Xinghua Yu
XZXiaowei Zeng
Xiaowei Zeng
QXQuanlan Xiao
Quanlan Xiao
Lin MeiLin Mei
Lin Mei

1 January 2016 in Theranostics
Verified
Journal Article
Open access
WTWei Tao
Wei Tao
XZXiaowei Zeng
Xiaowei Zeng
JWJun Wu
Jun Wu
XZXi Zhu
Xi Zhu
XYXinghua Yu
Xinghua Yu
Lin MeiLin Mei
Lin Mei
In this study, we reported a simple polydopamine (pD)-based surface modification method to prepare novel nanoparticle-aptamer bioconjugates (Apt-pD-DTX/NPs) for in vivo tumor targeting and enhanced therapeutic effects of breast cancer. With simple preparation procedures, the new functionalized Apt-pD-DTX/NPs could maximumly increase the local effective drug concentration on tumor sites, achieving enhanced treatment effectiveness and minimizing side effects. The dopamine polymerization and aptamer conjugation barely changed the characters of NPs. Both in vitro cell experiments (i.e. endocytosis of fluorescent NPs, in vitro cellular targeting and cytotoxicity assays) and in vivo animal studies (i.e. in vivo imaging, biodistribution and antitumor effects of NPs) demonstrated that the Apt-pD-DTX/NPs could achieve significantly high targeting efficiency and enhanced therapeutic effects compared with clinical Taxotere® and NPs without functional modification. Above all, the Apt-pD-DTX/NPs showed great potential as a promising nanoformulation for in vivo breast cancer therapy and the construction of pD-modified NP-aptamer bioconjugates could be of great value in medical use.

1 June 2016 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
WTWei Tao
Wei Tao
GXGuojun Xu
Guojun Xu
XYXinghua Yu
Xinghua Yu
JZJinxie Zhang
Jinxie Zhang
YSYingchao Sheng
Yingchao Sheng
LMLin Mei
Lin Mei
Robust aptamer–polydopamine-functionalized M-PLGA–TPGS nanoparticles for targeted delivery of docetaxel and enhanced cervical cancer therapy Guojun Xu,1–3,* Xinghua Yu,2,* Jinxie Zhang,1,2,* Yingchao Sheng,4 Gan Liu,2 Wei Tao,1,2 Lin Mei1,2 1School of Life Sciences, Tsinghua University, Beijing, 2Graduate School at Shenzhen, Tsinghua University, Shenzhen, 3School of Materials Science and Engineering, Tsinghua University, Beijing, 4Department of Orthopedic Surgery, Changshu Hospital of TCM, Changshu, People’s Republic of China *These authors contributed equally to this work One limitation of current biodegradable polymeric nanoparticles (NPs) is the contradiction between functional modification and maintaining formerly excellent bioproperties with simple procedures. Here, we reported a robust aptamer–polydopamine-functionalized mannitol-functionalized poly(lactide-co-glycolide) (M-PLGA)–D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) nanoformulation (Apt-pD-NPs) for the delivery of docetaxel (DTX) with enhanced cervical cancer therapy effects. The novel DTX-loaded Apt-pD-NPs possess satisfactory advantages: 1) increased drug loading content and encapsulation efficiency induced by star-shaped copolymer M-PLGA–TPGS; 2) significant active targeting effect caused by conjugated AS1411 aptamers; and 3) excellent long-term compatibility by incorporation of TPGS. Therefore, with simple preparation procedures and excellent bioproperties, the new functionalized Apt-pD-NPs could maximally increase the local effective drug concentration on tumor sites, achieving enhanced treatment effectiveness and minimizing side effects. In a word, the robust DTX-loaded Apt-pD-NPs could be used as potential nanotherapeutics for cervical cancer treatment, and the aptamer–polydopamine modification strategy could be a promising method for active targeting of cancer therapy with simple procedures. Keywords: dopamine, AS1411 aptamer, active targeting, polymeric NPs, enhanced cervical chemotherapy

1 September 2013 in Ceramics International
Verified
Journal Article
Closed access
WLWentao Liu
Wentao Liu
XWXin Wang
Xin Wang
XGXiaohan Gao
Xiaohan Gao
XCXiaofeng Chen
Xiaofeng Chen
XYXinghua Yu
Xinghua Yu
XDXuming Deng
Xuming Deng

2 January 2017 in Advanced Materials
Verified
Journal Article
Open access
PDF file
WTWei Tao
Wei Tao
XZXianbing Zhu
Xianbing Zhu
XYXinghua Yu
Xinghua Yu
XZXiaowei Zeng
Xiaowei Zeng
QXQuanlan Xiao
Quanlan Xiao
LMLin Mei
Lin Mei
In article 1603276, J. Shi, H. Zhang, L. Mei, and co‐workers describe black phosphorus nanosheets (BP NSs), which could lead to an enhanced antitumor effect, by a triple‐response combined therapy strategy. When they enter the cancer cell, the BP NSs can produce a local high temperature initiated by an 808 nm laser. Release of loaded doxorubicin can be triggered by the laser and heat, leading to a combined photothermal–chemotherapy effect, which effectively kills the cancer cell. Moreover, under the influence of chloroquine, the degradation of BP NSs in the lysosome can be inhibited. The drug is then concentrated in the cell nucleus.